SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Avian ("Bird") Flu Stocks
NNVC 1.680-8.7%3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: sammy™ -_-5/26/2006 9:12:30 PM
  Read Replies (1) of 428
 
Focusing on one strain of flu out of the large universe of possible candidates for a killer pandemic is the wrong strategy. The focus should be on improving the response to the yearly epidemics. This will make us better prepared if a deadly strain emerges, and will save thousands of lives and billions in economic losses every year. There should be stable, long term funding for vaccine purchase, and it should include enough redundant vaccine to allow for manufacturing failures, bad guesses on the pandemic strain, and to avoid distribution bottlenecks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext